Faeth Therapeutics Announces Investor Engagement, Analyst Support, and PIKTOR Phase II Highlights
Faeth Therapeutics announces investor events and analyst support, spotlighting its PIKTOR multi‑node oncology therapy and promising Phase II data.
2 minutes to read